Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Rawłuszko, Agnieszka A ^a   Horbacka, Karolina ^a   Krokowicz, Piotr ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1; 5 AZA 2' DEOXYCYTIDINE; DNA DIRECTED DNA POLYMERASE; ESTRADIOL; ESTRONE; GENOMIC DNA; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; ESTRADIOL 17BETA DEHYDROGENASE; HSD17B1 PROTEIN, HUMAN; TUMOR PROTEIN;

17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 GENE; ADULT; AGE; AGED; ARTICLE; ASCENDING COLON; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CANCER TISSUE; CHEMOLUMINESCENCE; CHROMATIN IMMUNOPRECIPITATION; COLON ADENOCARCINOMA; COLON MUCOSA; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DESCENDING COLON; DNA DEMETHYLATION; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; ELECTROCHEMOLUMINESCENCE; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; HIGH RESOLUTION MELTING ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; SEX DIFFERENCE; TRANSCRIPTION REGULATION; TUMOR LOCALIZATION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ANALYSIS OF VARIANCE; CELL STRAIN HT29; COLON TUMOR; COLORECTAL TUMOR; ENZYMOLOGY; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA METHYLATION; ESTRADIOL DEHYDROGENASES; FEMALE; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 84857065334     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-522     Document Type: Article

References (60)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2008, 46(4):765-781.
3. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007, 96(5):828-831. 10.1038/sj.bjc.6603628, 2360074, 17311019.
4. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000, 88(10):2398-2424. 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I, 10820364.
5. Qiu Y, Langman MJ, Eggo MC. Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?. J Endocrinol 2004, 181(2):327-337. 10.1677/joe.0.1810327, 15128281.
6. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. Jama 2002, 288(7):872-881. 10.1001/jama.288.7.872, 12186605.
7. Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 2009, 27(27):4542-4547. 10.1200/JCO.2009.22.0764, 2754905, 19704062.
8. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003, 86(3-5):225-230. 10.1016/S0960-0760(03)00360-1, 14623515.
9. Mindnich R, Moller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2004, 218(1-2):7-20. 10.1016/j.mce.2003.12.006, 15130507.
10. Luu The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R, et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta. Mol Endocrinol 1989, 3(8):1301-1309. 10.1210/mend-3-8-1301, 2779584.
11. Luu-The V, Labrie C, Simard J, Lachance Y, Zhao HF, Couet J, Leblanc G, Labrie F. Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes. Mol Endocrinol 1990, 4(2):268-275. 10.1210/mend-4-2-268, 2330005.
12. Miettinen MM, Mustonen MV, Poutanen MH, Isomaa VV, Vihko RK. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J 1996, 314(Pt 3):839-845. 1217133, 8615778.
13. Poutanen M, Moncharmont B, Vihko R. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res 1992, 52(2):290-294.
14. Kondo Y. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J 2009, 50(4):455-463. 10.3349/ymj.2009.50.4.455, 2730606, 19718392.
15. Luczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006, 44(3):143-154.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159.
17. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313(4):856-862. 10.1016/j.bbrc.2003.11.177, 14706621.
18. Szabo A, Perou CM, Karaca M, Perreard L, Palais R, Quackenbush JF, Bernard PS. Statistical modeling for selecting housekeeper genes. Genome Biol 2004, 5(8):R59. 10.1186/gb-2004-5-8-r59, 507884, 15287981.
19. EMBOSS CpGPlot/CpGReport/Isochore. , http://www.ebi.ac.uk/emboss/cpgplot/
20. CpG Island Searcher. , http://cpgislands.usc.edu/
21. UCSC Genome Bioinformatics Site. , http://genome.ucsc.edu/
22. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinforma (Oxford, England) 2005, 21(21):4067-4068.
23. Rohde C, Zhang Y, Jurkowski TP, Stamerjohanns H, Reinhardt R, Jeltsch A. Bisulfite sequencing Data Presentation and Compilation (BDPC) web server--a useful tool for DNA methylation analysis. Nucleic Acids Res 2008, 36(5):e34. 10.1093/nar/gkn083, 2275153, 18296484.
24. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007, 35(6):e41. 10.1093/nar/gkm013, 1874596, 17289753.
25. Abcam ChIP kit protocol. , http://www.abcam.com/index.html?pageconfig=protocols&pid=1124&intAbID=500&strTab=protocols&mode=prot
26. Kim YI. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 2005, 135(11):2703-2709.
27. Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control 2009, 20(8):1397-1408. 10.1007/s10552-009-9366-3, 19466571.
28. van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, Jenab M, Boshuizen HC, Ros MM, Casagrande C, Tjonneland A, Olsen A, Overvad K, et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. American J Clin Nutr 2009, 89(5):1441-1452.
29. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767. 10.1016/0092-8674(90)90186-I, 2188735.
30. Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010, 29(1):181-206. 10.1007/s10555-010-9207-6, 20135198.
31. Miyakura Y, Sugano K, Konishi F, Ichikawa A, Maekawa M, Shitoh K, Igarashi S, Kotake K, Koyama Y, Nagai H. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterol 2001, 121(6):1300-1309.
32. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. New England J Med 2004, 350(10):991-1004.
33. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333. 10.1001/jama.288.3.321, 12117397.
34. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Strom A, Gustafsson JA. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res 2009, 69(15):6100-6106. 10.1158/0008-5472.CAN-09-0506, 19602591.
35. Castiglione F, Taddei A, Degl'Innocenti DR, Buccoliero AM, Bechi P, Garbini F, Chiara FG, Moncini D, Cavallina G, Marascio L, et al. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol 2008, 17(4):231-236. 10.1097/PDM.0b013e3181656d67, 19034156.
36. Weige CC, Allred KF, Allred CD. Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res 2009, 69(23):9118-9124. 10.1158/0008-5472.CAN-09-2348, 19903848.
37. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept signal 2008, 6:e003. 2254331, 18301783.
38. Papaxoinis K, Triantafyllou K, Sasco AJ, Nicolopoulou-Stamati P, Ladas SD. Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: implications for carcinogenesis and colorectal cancer epidemiology. Eur J Gastroenterol Hepatol 2010, 22(5):614-619. 10.1097/MEG.0b013e328335ef50, 20173645.
39. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994, 7(4):536-540. 10.1038/ng0894-536, 7951326.
40. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001, 96(3):882-886. 10.1111/j.1572-0241.2001.03638.x, 11280569.
41. Sarli L, Michiara M, Sgargi P, Iusco D, De Lisi V, Leonardi F, Bella MA, Sgobba G, Roncoroni L. The changing distribution and survival of colorectal carcinoma: an epidemiological study in an area of northern Italy. Eur J Gastroenterol Hepatol 2005, 17(5):567-572. 10.1097/00042737-200505000-00014, 15827448.
42. Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007, 67(5):2366-2372. 10.1158/0008-5472.CAN-06-3026, 17332369.
43. Fiorelli G, Picariello L, Martineti V, Tognarini I, Tonelli F, Brandi ML. Estrogen metabolism in human colorectal cancer cells. J Steroid Biochem Mol Biol 2002, 81(3):281-289. 10.1016/S0960-0760(02)00075-4, 12163140.
44. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100(1):57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
45. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002, 160(5):1823-1830. 10.1016/S0002-9440(10)61128-5, 1850869, 12000733.
46. Suehiro Y, Hinoda Y. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps. Cancer Sci 2008, 99(6):1071-1076. 10.1111/j.1349-7006.2008.00784.x, 18384435.
47. Qu Z, Yan P, Fu J, Jiang J, Grusby MJ, Smithgall TE, Xiao G. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res 2010, 70(5):1766-1772. 10.1158/0008-5472.CAN-09-3263, 3003295, 20145149.
48. Belanger AS, Tojcic J, Harvey M, Guillemette C. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC mol biol 2010, 11:9. 10.1186/1471-2199-11-9, 2835698, 20096102.
49. Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, Majumder S, Bai S, Majumder A, Huang T, et al. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. PloS one 2010, 5(4):e10338. 10.1371/journal.pone.0010338, 2861599, 20454457.
50. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006, 25(36):4986-4997. 10.1038/sj.onc.1209505, 16568088.
51. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathol 2007, 50(1):113-130.
52. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003, 12(8):755-762.
53. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999, 96(15):8681-8686. 10.1073/pnas.96.15.8681, 17576, 10411935.
54. Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976, 36(12):4562-4569.
55. von Kleist S, Chany E, Burtin P, King M, Fogh J. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst 1975, 55(3):555-560.
56. Site UGB. UCSC Genome Bioinformatics Site.
57. Lorincz MC, Dickerson DR, Schmitt M, Groudine M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 2004, 11(11):1068-1075. 10.1038/nsmb840, 15467727.
58. Tian XQ, Zhang Y, Sun D, Zhao S, Xiong H, Fang J. Epigenetic silencing of LRRC3B in colorectal cancer. Scand J gastroenterol 2009, 44(1):79-84. 10.1080/00365520802400834, 18815942.
59. Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. BMC Cancer 2010, 10:160. 10.1186/1471-2407-10-160, 2868053, 20423473.
60. Lin J, Lai M, Huang Q, Ruan W, Ma Y, Cui J. Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro. Cancer biol ther 2008, 7(12):1896-1900. 10.4161/cbt.7.12.6937, 18981723.